DE3584300D1 - Herstellung von malaria-impfstoffen. - Google Patents

Herstellung von malaria-impfstoffen.

Info

Publication number
DE3584300D1
DE3584300D1 DE8585301110T DE3584300T DE3584300D1 DE 3584300 D1 DE3584300 D1 DE 3584300D1 DE 8585301110 T DE8585301110 T DE 8585301110T DE 3584300 T DE3584300 T DE 3584300T DE 3584300 D1 DE3584300 D1 DE 3584300D1
Authority
DE
Germany
Prior art keywords
manufacture
malaria vaccines
malaria
vaccines
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE8585301110T
Other languages
English (en)
Inventor
Ian Allen Hope
John Graham Scaife
Jana Strambachova-Mcbride
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BTG International Ltd
Original Assignee
National Research Development Corp UK
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB848404493A external-priority patent/GB8404493D0/en
Priority claimed from GB848428643A external-priority patent/GB8428643D0/en
Priority claimed from GB848432337A external-priority patent/GB8432337D0/en
Application filed by National Research Development Corp UK filed Critical National Research Development Corp UK
Application granted granted Critical
Publication of DE3584300D1 publication Critical patent/DE3584300D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • C07K14/445Plasmodium
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/20Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans from protozoa
    • C07K16/205Plasmodium
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70Vectors or expression systems specially adapted for E. coli
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Plant Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
DE8585301110T 1984-02-21 1985-02-19 Herstellung von malaria-impfstoffen. Expired - Lifetime DE3584300D1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB848404493A GB8404493D0 (en) 1984-02-21 1984-02-21 Malaria vaccines
GB848428643A GB8428643D0 (en) 1984-11-13 1984-11-13 Production of malaria vaccines
GB848432337A GB8432337D0 (en) 1984-12-21 1984-12-21 Production of malaria vaccines

Publications (1)

Publication Number Publication Date
DE3584300D1 true DE3584300D1 (de) 1991-11-14

Family

ID=27262281

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8585301110T Expired - Lifetime DE3584300D1 (de) 1984-02-21 1985-02-19 Herstellung von malaria-impfstoffen.

Country Status (4)

Country Link
EP (1) EP0153188B1 (de)
AU (1) AU584881B2 (de)
DE (1) DE3584300D1 (de)
WO (1) WO1985003724A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2145092B (en) * 1983-01-28 1988-04-07 Univ New York Protective peptide antigen
US6716590B1 (en) * 1982-02-17 2004-04-06 D'antonio Lawrence E. Compositions comprised of antigenic factors associated with malaria parasites, and process for making same
CN86100979A (zh) * 1985-02-07 1986-12-17 史密丝克莱恩贝克曼公司 疟疾疫苗的制备方法
DE3686178T2 (de) * 1985-02-07 1993-03-11 Smithkline Beckman Corp Malaria-impfstoff.
EP0217877A4 (de) * 1985-04-11 1988-03-30 Inst Medical W & E Hall Sehr wiederholungsfähige antigene von plasmodium falciparum.
EP0229829B1 (de) * 1985-07-12 1995-02-22 New York University Mit dem plasmodium-vivax-circumsporozoit-protein übereinstimmendes immunogenes peptidantigen
US4693994A (en) * 1985-11-19 1987-09-15 The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Protective synthetic peptide against malaria and encoding gene
GB8615068D0 (en) * 1986-06-20 1986-07-23 Wellcome Found Vaccines
US5019511A (en) * 1986-07-31 1991-05-28 Reese Robert T Erythrocytic membrane antigens of P. falciparum-infected erythrocytes
FR2610631B1 (fr) * 1987-02-09 1989-11-24 Pasteur Institut Molecules comportant au moins une sequence peptidique porteuse d'un ou plusieurs, epitope caracteristique d'une proteine produite par p. falciparum dans les hepatocytes, et leurs utilisations, notamment pour le diagnostic du paludisme ou dans des compositions de vaccins contre le paludisme
US5231168A (en) * 1988-09-16 1993-07-27 Statens Seruminstitut Malaria antigen

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2145092B (en) * 1983-01-28 1988-04-07 Univ New York Protective peptide antigen
IL65496A (en) * 1981-04-15 1985-10-31 Wellcome Found Protozoal antigen,its preparation and vaccine containing it
GB2099300B (en) * 1981-05-21 1985-02-27 Wellcome Found Antigens from parasites of the genus plasmodium
AU569722B2 (en) * 1983-01-28 1988-02-18 Saramane Pty Ltd Expression of plasmodium falciparum polypeptides from cloned cdna
DE3583347D1 (de) * 1984-02-22 1991-08-08 Wellcome Found Klonieren von dna fuer protozoenantigene.
ZA855232B (en) * 1984-07-23 1986-02-26 Univ New York Protective peptide antigen corresponding to plasmodium falciparum circumsporozoite protein
IL76338A (en) * 1984-09-11 1994-08-26 Saramane Pty Ltd Plasmodium plasmodium immunogenic polypeptides, AND molecules encoding them, a method for preparing the polypeptides and preparations containing the polypeptide

Also Published As

Publication number Publication date
EP0153188A1 (de) 1985-08-28
AU584881B2 (en) 1989-06-08
AU3936585A (en) 1985-09-10
EP0153188B1 (de) 1991-10-09
WO1985003724A1 (en) 1985-08-29

Similar Documents

Publication Publication Date Title
DE3780933D1 (de) Herstellung von aminoalanen.
ATE72660T1 (de) Herstellung von zeolith-l.
DE3579719D1 (de) Herstellung von emulsionen.
DE68922524D1 (de) Herstellung von Bisphenolen.
DE3650339D1 (de) Herstellung von Urandioxid-Material.
DE3689555D1 (de) Herstellung von aliphatischen Polyaminen.
DE3675680D1 (de) Herstellung von guanidinen.
DE3481568D1 (de) Herstellung von photodioden.
ATE38211T1 (de) Herstellung von zeolith-l.
DE3584503D1 (de) Herstellung von emulsionen.
DE3584300D1 (de) Herstellung von malaria-impfstoffen.
DE3683660D1 (de) Herstellung von halogenierten benzolen.
ATE78869T1 (de) Malaria-impfstoff.
DE3687071D1 (de) Malaria-impfstoff.
DE3872996D1 (de) Herstellung von tertiaerem butylalkohol.
DE3770889D1 (de) Herstellung von kubischem bornitrid.
DE3382074D1 (de) Herstellung von hydroxyarylaldehyden.
DE68921340D1 (de) Herstellung von epoxinitraten.
DE3773028D1 (de) Herstellung von zimtsaeuren.
DE3875281D1 (de) Herstellung von pseudoiononen.
DE3381907D1 (de) Herstellung von trifluormethylpyridinen.
DE3582003D1 (de) Herstellung von glycolmonoestern.
DE3650007D1 (de) Herstellung von Maleimid.
DE3579284D1 (de) Herstellung von l-karnitin.
DE69002496D1 (de) Herstellung von fluorphenolen.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: BRITISH TECHNOLOGY GROUP LTD., LONDON, GB

8328 Change in the person/name/address of the agent

Free format text: KRAUS, W., DIPL.-CHEM. DR.RER.NAT. WEISERT, A., DIPL.-ING. DR.-ING., 80539 MUENCHEN SPIES, J., DIPL.-PHYS., PAT.-ANWAELTE, 81545 MUENCHEN

8339 Ceased/non-payment of the annual fee